A clinical model that treats obesity as a disease and supports metabolic health assessment, metabolic health checks, and clearer metabolic syndrome risk stratification.
The ABCD Framework
Understand the 4 stages of adiposity-based chronic disease.
ABCD is a complication-centric model. By shifting focus from weight to pathophysiology, we move beyond BMI toward data-driven systemic health.
Early detection of metabolic predisposition and adiposity pathophysiology.
Targeted intervention for subclinical complications and organ stress.
Advanced management of manifest clinical complications.
Comprehensive tertiary care for structural damage and functional impairment.
Weight is a proxy, not a diagnosis. By evaluating adipose tissue dysfunction, clinicians can prescribe interventions tailored to metabolic phenotype.
Targeted titration based on severity.
Focus on cardiovascular restoration.
"The shift to ABCD allows for a medically relevant diagnosis of obesity as a chronic disease."
Moving beyond mass to metabolic mapping. A comprehensive evaluation of five critical systemic drivers.
Live Data Stream
Lead Diagnostic
Advanced Adiposity Analysis Protocol
2026 Global Standard
Our staging framework aligns with latest clinical consensus reports for metabolic health.
Insulin & Lipid Pathways
Skeletal Integrity
Vascular Precision
Pathophysiological Analysis
Systemic Signaling
Have questions about the ABCD staging protocol or interested in collaboration? Our medical desk is here to assist.
Primary Contact
[email protected]Explore key guides on adiposity-based chronic disease, staging, symptoms, treatment, prevention, and cardiometabolic risk.
Adiposity-Based Chronic Disease (ABCD) is a clinical framework that classifies disease by complication severity across organ systems rather than BMI alone. It recognizes obesity as a disease and enables personalized metabolic health management through staged interventions.
The ABCD model defines obesity as a disease because it focuses on the metabolic dysfunction and complications caused by adiposity, not just excess weight. This includes metabolic, biomechanical, cardiovascular, and psychological complications that require medical management.
Metabolic health assessment in ABCD evaluates insulin resistance, lipid profiles, glucose control, and inflammatory markers to determine disease severity and treatment needs, rather than relying on BMI or weight alone.
ABCD identifies and stages metabolic syndrome risk by assessing complications across multiple systems. It provides targeted interventions at each stage to reduce metabolic syndrome risk and prevent disease progression.
A metabolic health check evaluates metabolic markers, organ-specific complications, and disease stage under the ABCD framework. It assesses risk factors and guides treatment decisions independent of BMI or appearance.